AzTrials
AzTrials

HypotensionICU-HypoAINCT07627607

Early Prediction of ICU Hypotension Using Machine Learning

An observational study of Hypotension, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective observational study aims to develop and internally validate a machine learning model for the early prediction of hypotension in adult intensive care unit patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hypotension
What is being tested?
Routine ICU Data Collection
How many people
107 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Mar 2026to 30 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of consecutive adult patients monitored in the adult intensive care unit of Kutahya Health Sciences University during the study period. Routine clinical monitoring data, including non-invasive blood pressure, heart rate, medication-dose records, and fluid-balance data, will be used for machine learning model development and internal validation. No treatment or intervention will be assigned by the study protocol.

Who may be able to join

  • Age 18 years or older
  • Admission to the adult intensive care unit during the study period
  • Length of stay in the intensive care unit of at least 24 hours
  • Availability of routine intensive care unit monitoring data
  • Availability of non-invasive blood pressure and heart rate measurements recorded during ICU monitoring
  • Availability of medication-dose and/or fluid-balance records during ICU monitoring

Who cannot join

  • Age younger than 18 years
  • Length of stay in the intensive care unit of less than 24 hours
  • Absence of usable blood pressure monitoring data
  • Records with irrecoverable timestamp inconsistencies
  • Insufficient monitoring duration for feature construction and future outcome labeling

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Kutahya City Hospital

    Kütahya, Kütahya, 43100

Other trials in Turkey (Türkiye)

About this study

Official title: A Prospective Observational Machine Learning Study for the Early Prediction of Hypotension in Adult Intensive Care Unit Patients

This prospective observational study aims to develop and internally validate a machine learning model for the early prediction of hypotension in adult intensive care unit patients. The model will use routinely collected non-invasive vital signs, heart rate, medication-dose records, and fluid-balance data recorded during standard ICU care. No intervention will be assigned by the study, and patient management will not be changed according to the model output. The primary aim is to predict hypotension 30 minutes before its occurrence; shorter 5- and 15-minute prediction horizons will also be evaluated.

Read the detailed description

Hypotension is a frequent hemodynamic event in critically ill patients and may occur before clear clinical deterioration is recognized. Earlier identification of patients at risk may support closer clinical attention and more timely evaluation. This study is designed as a prospective, observational machine learning study in adult intensive care unit patients.

Routinely available ICU data will be collected at five-minute intervals, including systolic, mean, and diastolic non-invasive blood pressure, heart rate, medication-dose entries, and fluid-balance records. These data will be used to construct time-dependent features reflecting recent values, short-term changes, and rolling trends. Hypotension will be defined at each five-minute time point as systolic blood pressure below 90 mmHg, mean arterial pressure below 65 mmHg, or diastolic blood pressure below 60 mmHg.

The primary prediction horizon will be 30 minutes. Separate secondary analyses will evaluate 5- and 15-minute prediction horizons. A gradient-boosted decision-tree model will be developed and internally validated using patient-level data partitioning to avoid assigning observations from the same patient to both training and validation sets. Model performance will be assessed using discrimination, classification performance, and calibration measures. Feature-importance analyses will be used to describe the variables contributing to model predictions.

The study is observational. No treatment, medication, device, alarm, or clinical decision will be assigned by the study protocol. The prediction model will be developed and evaluated using collected data and will not be used to guide real-time patient management during the study period.

Conditions
Hypotension
Being tested
Routine ICU Data Collection
Keywords
Intensive Care Unit, Machine Learning, Artificial Intelligence, Non-Invasive Blood Pressure, Hemodynamic Monitoring, Prediction Model
Medical subject headings
Hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Routine ICU Data CollectionOther

    Routinely collected intensive care unit data, including non-invasive blood pressure, heart rate, medication-dose records, and fluid-balance data, will be recorded and analyzed for development and internal validation of a machine learning model. The study does not assign any treatment, medication, device, alarm, or clinical decision.

Study groups in NCT07627607
Study groupRoleWhat they receive
Adult Intensive Care Unit PatientsAdult patients admitted to the intensive care unit who are monitored during routine clinical care. Routinely collected non-invasive blood pressure, heart rate, medication-dose, and fluid-balance data will be used for machine learning model development and internal validation. No treatment or clinical intervention will be assigned by the study protocol.
Receives: Other: Routine ICU Data Collection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Area Under the Receiver Operating Characteristic Curve for 30-Minute Hypotension Prediction

    Discriminative performance of the machine learning model for predicting hypotension 30 minutes before its occurrence. Hypotension will be defined as systolic blood pressure below 90 mmHg, mean arterial pressure below 65 mmHg, or diastolic blood pressure below 60 mmHg at a five-minute observation point.

    Measured: From enrollment through the end of ICU monitoring, up to 4 months

Secondary outcomes (2)
  1. Area Under the Receiver Operating Characteristic Curve for 5- and 15-Minute Hypotension Prediction

    Discriminative performance of separate machine learning models for predicting hypotension at 5-minute and 15-minute prediction horizons.

    Measured: From enrollment through the end of ICU monitoring, up to 4 months

  2. Classification Performance of the Hypotension Prediction Model

    Classification performance of the machine learning model will be assessed using sensitivity, specificity, positive predictive value, negative predictive value, and F1 score at predefined classification thresholds.

    Measured: From enrollment through the end of ICU monitoring, up to 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2026
  2. Study start15 Mar 2026
  3. Primary completion30 Jun 2026
  4. Study completion30 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
107 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07627607
Sponsor's protocol ID
2026/03-15
Acronym
ICU-HypoAI
Status last verified
Jul 2026
First submitted
31 May 2026
Last updated
9 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hypotension, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Area Under the Receiver Operating Characteristic Curve for 30-Minute Hypotension Prediction (time frame: From enrollment through the end of ICU monitoring, up to 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in